kbh/ dndn is a totally broken one now, 5 seems to have some longer term support.....Their ceo Gold has overpromised (much like gerons okarma)...but i think what might be holding dndn back is the nature of their provenge, in that "can" they make money administerring it if it ever gets approved.....i think it does show "some" benefit with little side effects....but the specific approach of provenge may be cost inefective for them...as you may have said, down the road cancer care might be combo therapy of many many things, keeping it in check..and gerns approach has a shot in that area too..but man, they love to crush these small bios!!!!!
i stil love cris for longer term play..and ingn has held up well in the mini nassacre.
one day, gern is gonna break free of the reigns holding it back
>new short on kbh 123.94
Market Data 
Markets 
AI
